Skip to main content
. 2019 Mar 7;41(5):2790–2802. doi: 10.3892/or.2019.7049

Figure 9.

Figure 9.

Schema of the mechanism between PRL-3, MAPK and NF-κB. PRL-3, phosphatase of regenerating liver-3; CRC, colorectal cancer; EMT, epithelial-mesenchymal transition; CCL26, chemokine ligand 26; IL, interleukin; CCR3, C-C chemokine receptor type 3; MAPK, mitogen-activated protein kinase; TAM, tumor-associated macrophages.